UNC Charlotte researchers are contributing to pioneering breakthroughs in cancer therapeutics, communicable disease ...

A one-time injection of a novel gene therapy was able to save mice and a newborn calf from succumbing to maple syrup urine ...

Financially, Monopar has a cash runway until 2026 but will need additional funds for commercialization efforts. See why I'm ...

“Gene therapy for hemophilia A with the use of lentiviral vector-transduced autologous HSCs resulted in stable factor VIII expression, with factor VIII activity correlating to vector copy number in ...

The Phase 3 ARTEMIS trial (NCT06856577) is designed to evaluate the safety and efficacy of Ixo-vec in a randomized (1:1), double-masked, sham-controlled, two-arm study. The US-based trial is intended ...

A promising study out of the United Kingdom has partially restored the vision of multiple small children born legally blind.

Abeona Therapeutics Inc. (Nasdaq: ABEO) today announced it has granted equity awards to new non-executive employees who ...

Welcome to the BioLife Solutions Q4 2024 shareholder and analyst conference call. (Operator Instructions). As a reminder, today's call is being recorded. I would now like to turn the conference call ...

Cash Position: As of December 31, 2024, Fractyl had approximately $67.5 million in cash and cash equivalents. Based on ...

Researchers at Fred Hutch Cancer Center have discovered an overlooked mechanism driving aggressive breast and brain tumors ...

BOTHELL, Wash. - BioLife Solutions, Inc. (NASDAQ: BLFS ), a leading provider of cell processing tools for the cell and gene therapy market, saw its shares jump 7.9% after reporting ...

The latest freezer and incubator technology aims to better preserve sample integrity and enable more physiologically-relevant ...